UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 25

Sortiert nach

Plasma pharmacokinetics and urinary excretion of tenofovir following cessation in adults with controlled levels of adherence to tenofovir disoproxil fumarate

International journal of infectious diseases, 2020-08, Vol.97, p.365-370

2020

Volltextzugriff (PDF)

Simplifying TREAtment and Monitoring for HIV (STREAM HIV): protocol for a randomised controlled trial of point-of-care urine tenofovir and viral load testing to improve HIV outcomes

BMJ open, 2021-10, Vol.11 (10), p.e050116-e050116

2021

Volltextzugriff (PDF)

Expanding options of child-friendly, single-tablet regimens for young children with HIV

The lancet HIV, 2024-05, Vol.11 (5), p.e275-e276

2024

Volltextzugriff (PDF)

Nevirapine Exposure with WHO Pediatric Weight Band Dosing: Enhanced Therapeutic Concentrations Predicted Based on Extensive International Pharmacokinetic Experience

Antimicrobial Agents and Chemotherapy, 2012-10, Vol.56 (10), p.5374-5380

2012

Volltextzugriff (PDF)

Development and validation of the first point-of-care assay to objectively monitor adherence to HIV treatment and prevention in real-time in routine settings

AIDS (London), 2020-02, Vol.34 (2), p.255-260

2020

Volltextzugriff (PDF)

Point-of-care semi-quantitative test for adherence to tenofovir alafenamide or tenofovir disoproxil fumarate

Journal of antimicrobial chemotherapy, 2022-03, Vol.77 (4), p.996-999

2022

Volltextzugriff (PDF)

Urine Tenofovir Concentrations Correlate With Plasma and Relate to Tenofovir Disoproxil Fumarate Adherence: A Randomized, Directly Observed Pharmacokinetic Trial (TARGET Study)

Clinical infectious diseases, 2020-05, Vol.70 (10), p.2143-2151

2020

Volltextzugriff (PDF)

Simultaneous pharmacokinetic modeling of unbound and total darunavir with ritonavir in adolescents: a substudy of the SMILE trial

Antimicrobial agents and chemotherapy, 2024-02, Vol.68 (2), p.e0100423-e0100423

2024

Volltextzugriff (PDF)

Pharmacokinetic Optimization of Antiretroviral Therapy in Pregnancy

Clinical pharmacokinetics, 2012-10, Vol.51 (10), p.639-659

2012

Volltextzugriff (PDF)

Paediatric abacavir–lamivudine fixed-dose dispersible tablets and ritonavir-boosted lopinavir granules in neonates exposed to HIV (PETITE study): an open-label, two-stage, single-arm, phase 1/2, pharmacokinetic and safety trial

The lancet HIV, 2024-02, Vol.11 (2), p.e86-e95

2024

Volltextzugriff (PDF)

Population pharmacokinetics of unbound and total dolutegravir concentrations in children aged 12 years and older: a PK substudy of the SMILE trial

Journal of antimicrobial chemotherapy, 2023-04, Vol.78 (4), p.1041-1049

2023

Volltextzugriff (PDF)

Point-of-care and Near Real-time Testing for Antiretroviral Adherence Monitoring to HIV Treatment and Prevention

Current HIV/AIDS reports, 2020-10, Vol.17 (5), p.487-498

2020

Volltextzugriff (PDF)

Does pregnancy affect the pharmacokinetics of efavirenz?

AIDS (London), 2014-06, Vol.28 (10), p.1542-1543

2014

Volltextzugriff (PDF)

Youth‐friendly services and a mobile phone application to promote adherence to pre‐exposure prophylaxis among adolescent men who have sex with men and transgender women at‐risk for HIV in Thailand: a randomized control trial

Journal of the International AIDS Society, 2020-09, Vol.23 (S5), p.e25564-n/a

2020

Volltextzugriff (PDF)

Pharmacogenetics of antiretroviral drugs for the treatment of HIV-infected patients: An update

Infection, genetics and evolution, 2007-03, Vol.7 (2), p.333-342

2007

Volltextzugriff (PDF)

Novel Approaches to Postnatal Prophylaxis to Eliminate Vertical Transmission of HIV

Global health science and practice, 2023-04, Vol.11 (2), p.e2200401

2023

Volltextzugriff (PDF)

Optimization of the strength of the efavirenz/lamivudine/abacavir fixed-dose combination for paediatric patients

Journal of antimicrobial chemotherapy, 2017-02, Vol.72 (2), p.490-495

2017

Volltextzugriff (PDF)

Rilpivirine Pharmacokinetics Without and With Darunavir/Ritonavir Once Daily in Adolescents and Young Adults

The Pediatric infectious disease journal, 2016-09, Vol.35 (9), p.e271-e274

2016

Volltextzugriff (PDF)

Prioritising the most needed paediatric antiretroviral formulations: the PADO4 list

The lancet HIV, 2019-09, Vol.6 (9), p.e623-e631

2019

Volltextzugriff (PDF)

What babies need: accelerating access to current and novel antiretroviral drugs in neonates through pharmacokinetic studies

The lancet HIV, 2022-09, Vol.9 (9), p.e649-e657

2022

Volltextzugriff (PDF)

Incidence of Tuberculosis and Associated Mortality in a Cohort of Human Immunodeficiency Virus-Infected Children Initiating Antiretroviral Therapy

Journal of the Pediatric Infectious Diseases Society, 2017-06, Vol.6 (2), p.161-167

2017

Volltextzugriff (PDF)

Weekends-off efavirenz-based antiretroviral therapy in HIV-infected children, adolescents, and young adults (BREATHER): a randomised, open-label, non-inferiority, phase 2/3 trial

The lancet HIV, 2016-09, Vol.3 (9), p.e421-e430

2016

Volltextzugriff (PDF)

Switching HIV treatment in adults based on CD4 count versus viral load monitoring: a randomized, non-inferiority trial in Thailand

PLoS medicine, 2013-08, Vol.10 (8), p.e1001494-e1001494

2013

Volltextzugriff (PDF)

1 – 25 von 25

Suche als RSS-Feed

Aktive Filter

Nur zeigenMit Volltextzugriff

ThemaAnti-Hiv Agents - Therapeutic Use

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(24)

Publikationsform

Artikel
(25)

Sprache

Englisch
(25)

Erscheinungsjahr

n.n

Thema

Humans
(25)
Life Sciences & Biomedicine
(25)
Science & Technology
(25)
Hiv Infections - Drug Therapy
(24)
Infectious Diseases
(20)
Female
(17)
Immunology
(12)
Adult
(11)
Male
(11)
Child
(10)
Adolescent
(9)
Hiv
(9)
Infant
(8)
Microbiology
(7)
Tenofovir - Therapeutic Use
(7)
Young Adult
(7)
Anti-Hiv Agents - Administration & Dosage
(6)
Anti-Hiv Agents - Pharmacokinetics
(6)
Human Immunodeficiency Virus
(6)

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Plasma pharmacokinetics and urinary excretion of tenofovir following cessation in adults with controlled levels of adherence to tenofovir disoproxil fumarate

Simplifying TREAtment and Monitoring for HIV (STREAM HIV): protocol for a randomised controlled trial of point-of-care urine tenofovir and viral load testing to improve HIV outcomes

Expanding options of child-friendly, single-tablet regimens for young children with HIV

Nevirapine Exposure with WHO Pediatric Weight Band Dosing: Enhanced Therapeutic Concentrations Predicted Based on Extensive International Pharmacokinetic Experience

Development and validation of the first point-of-care assay to objectively monitor adherence to HIV treatment and prevention in real-time in routine settings

Point-of-care semi-quantitative test for adherence to tenofovir alafenamide or tenofovir disoproxil fumarate

Urine Tenofovir Concentrations Correlate With Plasma and Relate to Tenofovir Disoproxil Fumarate Adherence: A Randomized, Directly Observed Pharmacokinetic Trial (TARGET Study)

Simultaneous pharmacokinetic modeling of unbound and total darunavir with ritonavir in adolescents: a substudy of the SMILE trial

Efficacy and Safety of 1-Month Postpartum Zidovudine-Didanosine to Prevent HIV-Resistance Mutations after Intrapartum Single-Dose Nevirapine

Pharmacokinetic Optimization of Antiretroviral Therapy in Pregnancy

Paediatric abacavir–lamivudine fixed-dose dispersible tablets and ritonavir-boosted lopinavir granules in neonates exposed to HIV (PETITE study): an open-label, two-stage, single-arm, phase 1/2, pharmacokinetic and safety trial

Population pharmacokinetics of unbound and total dolutegravir concentrations in children aged 12 years and older: a PK substudy of the SMILE trial

Point-of-care and Near Real-time Testing for Antiretroviral Adherence Monitoring to HIV Treatment and Prevention

Does pregnancy affect the pharmacokinetics of efavirenz?

Youth‐friendly services and a mobile phone application to promote adherence to pre‐exposure prophylaxis among adolescent men who have sex with men and transgender women at‐risk for HIV in Thailand: a randomized control trial

Pharmacogenetics of antiretroviral drugs for the treatment of HIV-infected patients: An update

Novel Approaches to Postnatal Prophylaxis to Eliminate Vertical Transmission of HIV

Optimization of the strength of the efavirenz/lamivudine/abacavir fixed-dose combination for paediatric patients

Rilpivirine Pharmacokinetics Without and With Darunavir/Ritonavir Once Daily in Adolescents and Young Adults

Prioritising the most needed paediatric antiretroviral formulations: the PADO4 list

Pharmacokinetics, safety, and tolerability of dispersible and immediate-release abacavir, dolutegravir, and lamivudine tablets in children with HIV (IMPAACT 2019): week 24 results of an open-label, multicentre, phase 1-2 dose-confirmation study

What babies need: accelerating access to current and novel antiretroviral drugs in neonates through pharmacokinetic studies

Incidence of Tuberculosis and Associated Mortality in a Cohort of Human Immunodeficiency Virus-Infected Children Initiating Antiretroviral Therapy

Weekends-off efavirenz-based antiretroviral therapy in HIV-infected children, adolescents, and young adults (BREATHER): a randomised, open-label, non-inferiority, phase 2/3 trial

Switching HIV treatment in adults based on CD4 count versus viral load monitoring: a randomized, non-inferiority trial in Thailand

Aktive Filter

Suchergebnisse filtern